KWF
Breast Cancer Risk in Families: Outreach and Registry
Full proposal deadline was 24 June 2025 (12:00 noon); funding decision October 2025 — call appears closed
Last verified:
KWF's Breast Cancer Risk in Families call funds €2-4 million in multidisciplinary research and infrastructure to identify, reach, and support individuals with very high breast cancer risk (BRCA1/2 or PALB2 mutations) and establish a registry for high-risk families in the Netherlands. The consortium-based programme requires a minimum of four partners spanning breast cancer screening, qualitative research, HTA, behavioural science, and communication expertise, with mandatory patient participation and early health-technology assessment. This was a one-off call; the full proposal stage closed 24 June 2025.
Details
| Funder | KWF |
| Budget | €2M–€4M (total across research and infrastructure) |
| Consortium | Required — minimum 4 partners including breast cancer screening researchers, societal organisations, qualitative research experts, HTA experts, behavioural scientists, and communication researchers |
| Application | 2-stage: pre-proposal (closed 25 Feb 2025) → full proposal (closed 24 June 2025); interviews mid-September 2025 |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Funds multidisciplinary research and infrastructure to identify, reach, and inform individuals with very high breast cancer risk (BRCA1/2 or PALB2 mutations) and to build a registry for high-risk families. Consortium of ≥4 partners required; patient/citizen participation plan mandatory; early HTA required. In-kind/matching contributions encouraged. Excludes exploratory risk-factor discovery, new screening technologies, and clinical trials.
Who Should Apply
- •Multidisciplinary consortia of ≥4 partners including breast cancer screening researchers, patient/citizen groups, qualitative and HTA experts
- •Dutch research institutions and societal organisations with capacity for implementation and outreach
- •Teams with expertise spanning behavioural science, health communication, and registry infrastructure
- •Applicants committed to embedding patient and family voices in design and governance
Key Dates
- •Full proposal deadline was 24 June 2025; call now closed
- •Two-stage process: pre-proposal (closed 25 February 2025), full proposal and interviews (mid-September 2025)
- •Funding decision October 2025
Tips for Applicants
- ✓Consortium composition is gating: KWF screens for diversity of expertise (screening, qualitative, HTA, behaviour, communication) before evaluating science.
- ✓Patient and citizen participation is mandatory, not advisory, embed co-design in your workplan and governance, not only in dissemination.
- ✓Early HTA is required; partner with an HTA expert and frame implementation costs alongside research outcomes from day one.
Frequently Asked Questions
What is the budget for the KWF Breast Cancer Risk in Families call?
€2-4 million total across the entire research and infrastructure project.
Who must be in the consortium for this KWF grant?
A minimum of four partners including breast cancer screening researchers, societal organisations, qualitative research experts, HTA experts, behavioural scientists, and communication researchers.
Is patient participation required in this KWF call?
Yes, a patient and citizen participation plan is mandatory and will be reviewed as part of the application.
What research is excluded from this KWF call?
Exploratory risk-factor discovery, new screening technologies, and clinical trials are not eligible.
Is this KWF call open again for future rounds?
No, this was a one-off call. The full proposal deadline was 24 June 2025 and the call is now closed.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from KWF
Exploration Call 2026-3
Deadline: 1 Sept 2026Proof of Concept
Deadline: 22 Sept 2026Up to €150,000 incl. VATLead4Life
Deadline: 22 Sept 2026€0.5M–€2M per project (total PPP subsidy budget €5M)Validation of Biomarkers
Deadline: 20 Oct 2026€0.8M–€2MImplementation of Biomarkers
Deadline: 20 Oct 2026€1M–€4M
Browse Related
Could Breast Cancer Risk in Families: Outreach and Registry be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →